HPV-mediated cervical carcinogenesis: concepts and clinical implications.
about
Prophylactic human papillomavirus vaccinesCervical cancer screening in developing countries at a crossroad: Emerging technologies and policy choicesNatural history of cervical intraepithelial neoplasia in pregnancy: postpartum histo-pathologic outcome and review of the literatureThe human papillomavirus E7 proteins associate with p190RhoGAP and alter its function.Adaptive evolution of a stress response proteinAugmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions.CCR2-V64I polymorphism is associated with increased risk of cervical cancer but not with HPV infection or pre-cancerous lesions in African women.Papillomas of the external ear canal: report of ten cases in Chinese patients with HPV in situ hybridizationEpidemiological investigation of the relationship between common lower genital tract infections and high-risk human papillomavirus infections among women in Beijing, China.Promoter methylation status of the tumor suppressor genes p16 and cadherin 1 in cervical intraepithelial neoplasiaLow- and high-risk human papillomavirus E7 proteins regulate p130 differentlyGene expression changes during HPV-mediated carcinogenesis: a comparison between an in vitro cell model and cervical cancer.Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysisHPV type-related chromosomal profiles in high-grade cervical intraepithelial neoplasia.Identification of protein biomarkers for cervical cancer using human cervicovaginal fluidHighly potent and specific siRNAs against E6 or E7 genes of HPV16- or HPV18-infected cervical cancersAssociation between human papillomavirus and human T-lymphotropic virus in indigenous women from the Peruvian Amazon.Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract.Green and black tea in relation to gynecologic cancersHPV-DNA integration and carcinogenesis: putative roles for inflammation and oxidative stress.Human papillomavirus testing in the prevention of cervical cancerMultiplex Identification of Human Papillomavirus 16 DNA Integration Sites in Cervical Carcinomas.Virus transcript levels and cell growth rates after naturally occurring HPV16 integration events in basal cervical keratinocytes.MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer.Lethality of PAK3 and SGK2 shRNAs to human papillomavirus positive cervical cancer cells is independent of PAK3 and SGK2 knockdownExpression of platelet derived growth factor family members and the potential role of imatinib mesylate for cervical cancer.Promoter hypermethylation of KLF4 inactivates its tumor suppressor function in cervical carcinogenesis.Human papillomavirus infection is rare in nonmalignant tonsil tissue in the UK: implications for tonsil cancer precursor lesions.Dynamic behavioural interpretation of cervical intraepithelial neoplasia with molecular biomarkers.Aberrant expression of microRNA-26b and its prognostic potential in human cervical cancer.Reduced expression of tissue factor pathway inhibitor-2 contributes to apoptosis and angiogenesis in cervical cancer.Cost-effectiveness analysis of human papillomavirus vaccination in South Africa accounting for human immunodeficiency virus prevalence.HPV infection and cervical neoplasia: associated risk factors.Transcriptomic analyses of genes differentially expressed by high-risk and low-risk human papilloma virus E6 oncoproteinsChromosomal biomarkers for detection of human papillomavirus associated genomic instability in epithelial cells of cervical cytology specimensThe prognostic value of squamous cell carcinoma antigen for predicting tumor recurrence in cervical squamous cell carcinoma patients.Direct human papillomavirus E6 whole-cell enzyme-linked immunosorbent assay for objective measurement of E6 oncoproteins in cytology samples.Laboratory and clinical aspects of human papillomavirus testingMethylation of Cervical Neoplastic Cells Infected With Human Papillomavirus 16Different effects of H2O2 treatment on cervical squamous carcinoma cells and adenocarcinoma cells.
P2860
Q24545449-71428F5F-7ACB-4964-ACF1-9C296371D600Q26775085-69F85627-6A05-410C-8BA2-81F10DBD56C4Q28072648-FA98AF76-D5C4-4A3C-8FFD-E4E168535AB7Q30410482-F681E27D-8FE6-4211-8CB6-943350280811Q33302100-B70012DE-9204-4A0C-BF00-B1FD7CB1A8C4Q33315601-883BCCEF-0F2E-4153-A6AA-D7FAB9E7AD4EQ33600422-C2D2A117-D06C-446B-831F-C1F1F7167F6CQ33611512-270A22DB-0B32-41C9-931D-E9A0187103EBQ33713068-A964539A-BC7B-4639-8859-8AE79F2180CCQ33751094-DEFD105F-220A-452C-AE18-11992925E023Q33819744-AB68758E-BCC1-49B5-A6AD-0E24962F99BCQ33860352-F7CF1058-DCDB-408A-A767-FA03A02582CFQ33883532-D3F54215-CD5C-40AA-9A4B-D7B2ACC93B4FQ34138292-28F303CC-D0B1-49AC-BB2E-47958ECCF929Q34172304-043B03DE-25BB-4C86-86F5-DC4237491824Q34365543-9EFEF744-D954-4EA9-866A-ADF8A609892BQ34406503-703578A3-6600-4B66-8DDE-AAA2CB7D7FBFQ34467932-74F8F372-1FED-40EA-A222-B1E90847E883Q34522434-20C3D151-5683-43BF-98C8-4F40652294FFQ34566683-404D681A-49D1-4971-8941-D0356EDA993EQ34616083-1ED796D7-0B6C-4C49-AD80-84BA68C3D75DQ34793429-5E24081D-05F1-4F1F-AC26-275B17C6664BQ34852955-76CB6A4B-AD8D-4E88-94A2-98E784A92E96Q34995302-03E21338-12F5-4432-BE95-09227A530AF3Q35007100-59C45BD2-6493-40B1-8A51-65113C729D02Q35082777-951EA14C-F06C-404C-B73D-6F6C9E4D959DQ35097588-EDDD4702-78AC-484A-A884-6573A4E7FB25Q35145756-D06DC3A1-1B4E-4E0B-9969-E9679327669EQ35774348-1DC6A1D6-74AA-45C2-9DA7-2F8C905FAB7FQ35854256-9F591885-0953-4F85-ABE6-85B3860CF25EQ35858377-9277893B-CE9F-465E-A6E4-55ECC9E76B2EQ35865134-1654A7B7-A969-4147-AB5F-DDEE31B63514Q35914231-A25654C3-DF32-4BAD-B35D-95D64AD6CDD7Q36064347-02EDC758-E776-40D1-BD27-BE416C0FB336Q36103433-FF7C7A8F-4017-4186-9668-31EBA397A1F3Q36107579-B2284FE7-7C8C-47EB-8DC2-BBC54A1C2975Q36191712-EC591800-345F-4C6D-B14A-78BABA8B32E7Q36311573-DB13DB24-2036-4783-A7F8-457E96969BE5Q36372288-F8611CF3-63B2-481C-BA1F-7CEA097078B9Q36419014-1794AC8A-A72D-4584-A5EB-7DB3C33F47A9
P2860
HPV-mediated cervical carcinogenesis: concepts and clinical implications.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
HPV-mediated cervical carcinogenesis: concepts and clinical implications.
@ast
HPV-mediated cervical carcinogenesis: concepts and clinical implications.
@en
HPV-mediated cervical carcinogenesis: concepts and clinical implications.
@nl
type
label
HPV-mediated cervical carcinogenesis: concepts and clinical implications.
@ast
HPV-mediated cervical carcinogenesis: concepts and clinical implications.
@en
HPV-mediated cervical carcinogenesis: concepts and clinical implications.
@nl
prefLabel
HPV-mediated cervical carcinogenesis: concepts and clinical implications.
@ast
HPV-mediated cervical carcinogenesis: concepts and clinical implications.
@en
HPV-mediated cervical carcinogenesis: concepts and clinical implications.
@nl
P2093
P2860
P356
P1476
HPV-mediated cervical carcinogenesis: concepts and clinical implications.
@en
P2093
Chris J L M Meijer
Daniëlle A M Heideman
Peter J F Snijders
Renske D M Steenbergen
P2860
P304
P356
10.1002/PATH.1866
P577
2006-01-01T00:00:00Z